News
New and exciting developments
JUNE 1, 2022
NIRvana Sciences Awarded Phase II SBIR Grant from NIGMS
RESEARCH TRIANGLE PARK, NC, JUNE 1, 2022 – NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins, today announced that it has been awarded a Phase I SBIR grant from the National Institute for General Medical Sciences (NIGMS) at the National Institutes of Health (NIH). READ MORE
May 4, 2022
NIRvana Sciences Becomes Semi-Finalist in Technology Showcase at CYTO 2022
RESEARCH TRIANGLE PARK, NC, May 4, 2022 – NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins, today announced that it has become a Semi-Finalist in the International Society for Advancement of Cytometry’s (ISAC) CYTO 2022 Technology Showcase being held in Philadelphia, PA USA.
May 1, 2022
NIRvana Sciences Purchases EcoChyll X1 Rotovap Chiller
RESEARCH TRIANGLE PARK, NC, May 1, 2022 – NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins, today announced that it is purchasing an environmentally friendlier chiller for its rotovap system from Ecodyst, a local company in Apex, North Carolina. READ MORE
NIRvana Sciences is taking multiplexing to the next level
Need more919.354.1053
7020 Kit Creek Road, Suite 230 Research Triangle Park, North Carolina 27709 USA